Search Results
Jun 29, 2026, 13:56 ET Smartee met en avant sa technologie de repositionnement mandibulaire et ses solutions d'aligneurs pour le sommeil lors du salon EOS 2026
multimedia:https://www.prnewswire.com/news-releases/smartee-met-en-avant-sa-technologie-de-repositionnement-mandibulaire-et-ses-solutions-daligneurs-pour-le-sommeil-lors-du-salon-eos-2026-302813544.html
More news about: Smartee Denti-Technology
Jun 29, 2026, 09:30 ET NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
treatments for neurodegenerative diseases, today announced that its Phase 2b PARADIGM study of PrimeC in amyotrophic lateral sclerosis (ALS) has successfully met its primary efficacy endpoint, demonstrating a statistically significant reduction in TDP-43 levels compared to placebo. This is the first randomized,
More news about: NeuroSense
Jun 29, 2026, 09:19 ET LA LÉGENDE DU FOOTBALL ORIBE PERALTA A PRIS LE RELAIS D'UN FAN POUR QU'IL NE MANQUE PAS LE MATCH MEXIQUE - RÉPUBLIQUE TCHÈQUE
mexicains interrogés s'attendent à manquer au moins un match de la Coupe du Monde de la FIFA 2026™ en raison de leurs obligations quotidiennes. Cela met en évidence le dilemme auquel beaucoup seront confrontés cet été, lors du plus grand tournoi de football, alors qu'ils devront concilier leurs responsabilités
More news about: Rexona
Jun 29, 2026, 09:00 ET Le Nouveau Film de Dometic Dévoile l'Innovation à l'Origine de la Technologie Primée DG3
en versions intégrale et abrégée sur la chaîne YouTube de Dometic. Dometic met également la vidéo à la disposition de ses concessionnaires agréés, installateurs, partenaires constructeurs de bateaux et autres acteurs de l'industrie
More news about: Dometic Group
Jun 29, 2026, 09:00 ET THE MEXICO FUND, INC. STRENGTHENS ITS DISCOUNT CONTROL MECHANISM AND ANNOUNCES A CONDITIONAL TENDER OFFER
(minus the costs and expenses related to the tender offer). The conditional tender offer will be triggered if either of the following conditions is met at the end of the three-year period commencing July 1, 2026 and ending on June 30, 2029 (the "Measurement Period"):The Fund's total
More news about: The Mexico Fund, Inc.
Jun 29, 2026, 09:00 ET NPower appoints Ross B. Dickman as Chief Executive Officer
standard when it comes to workforce development in technology," said Dickman. "For 25 years, NPower has demonstrated what's possible when talent is met with opportunity. As the workforce continues to evolve, ensuring more people have access to the skills, support, and connections needed to succeed has
More news about: NPower
Jun 29, 2026, 09:00 ET ARIANA GRANDE IN PARTNERSHIP WITH LUXE BRANDS LAUNCHES CLOUD AURORA, THE NEWEST ADDITION TO THE GLOBAL AWARD-WINNING CLOUD COLLECTION
Summer 2026, she returned to the stage for her first global tour in more than seven years with The Eternal Sunshine Tour, a sold-out tour that was met with rave reviews. She is also preparing to release her highly anticipated next studio album, Petal, on July 31, 2026. A multi-platinum recording
More news about: LUXE Brands
Jun 29, 2026, 09:00 ET ARIANA GRANDE IN PARTNERSHIP WITH LUXE BRANDS LAUNCHES CLOUD AURORA, THE NEWEST ADDITION TO THE GLOBAL AWARD-WINNING CLOUD COLLECTION
Summer 2026, she returned to the stage for her first global tour in more than seven years with The Eternal Sunshine Tour, a sold-out tour that was met with rave reviews. She is also preparing to release her highly anticipated next studio album, Petal, on July 31, 2026. A multi-platinum recording
More news about: LUXE Brands
Jun 29, 2026, 08:45 ET Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
pharmaceutical companies for worldwide commercialization. In our recently completed Phase 1 clinical trial conducted at Cleveland Clinic, the vaccine met all major primary endpoints, was safe and well tolerated, and generated immune responses in 74% of participants, supporting continued clinical development
More news about: Anixa Biosciences, Inc.
Jun 29, 2026, 08:39 ET Selefina Sweet & Spicy Dry Rubs Make Every Summer Cookout a Knockout
www.selefina.com."Summer grilling has met its match with these dry rubs that turn up the heat. Selefina creator collaborations and original blends bring fearless flavor to inspire grill masters
More news about: Selefina
Jun 29, 2026, 08:30 ET Bioness Medical Announces 510(k) Clearance for PoNS® (Portable Neuromodulation Stimulator) to Manage Patients Recovering from Stroke
allowed for analysis of the key secondary endpoints with the same methodology.SRP Study ResultsOverall, the primary endpoint was met and statistically significant for gait deficit (FGA). The primary analysis of the pooled pivotal randomized controlled and single-arm studies demonstrated
More news about: Bioness Medical, Inc.
Jun 29, 2026, 08:00 ET Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board
phosphate binder for hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis, with its registrational Phase III trial in China having met the primary endpoint, a New Drug Application (NDA) to the National Medical Products Administration (NMPA) planned for the near future, and its China-U.S.
More news about: Alebund Pharmaceuticals
Jun 29, 2026, 07:56 ET The PenFed Foundation for Military Heroes Celebrates Successful Honor Flight for Puerto Rico's Veteran Community
celebration of service and a tribute to fallen soldiers."I leave with a heart full of gratitude for the warm welcome and applause from everyone we met during our visit to Washington, D.C.," said Miguel Ángel Rodríguez Rivera Jr., a U.S. Army Vietnam Veteran from Carolina, Puerto Rico. "This has
More news about: PenFed Foundation
Jun 29, 2026, 06:59 ET Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
VR-205 Met Primary Endpoint and Key Secondary Endpoints and Was Well ToleratedVR-205 Efficacy and Safety Profile in Japanese Patients Was Consistent with the Profile Observed in Global Studies Japanese New Drug Application
More news about: Viatris Inc.
Jun 29, 2026, 06:20 ET Dr. Heather Pressler Joins NAWBO Circle, Becomes Inaugural Lifetime Legacy Member
Entrepreneurs"Joining the Circle is an honor and has been a goal of mine for years. As I've built BlueHuki, I've been inspired by the women I've met through NAWBO who lead successful businesses while generously sharing their experience with others," said Dr. Heather Pressler, Founder and CEO. "Also
More news about: BlueHuki Group LLC
Jun 29, 2026, 05:00 ET Auto Shop Answers Announces Bryan Stasch as Vice President of Coaching, Peer Groups & Member Success
achieve extraordinary success.""I've spent my career helping independent shop owners build businesses that support the life they truly want. When I met the leadership team at Auto Shop Answers and experienced their vision firsthand, I knew this was where I wanted to continue that mission.The passion,
More news about: Autoshop Answers
Jun 29, 2026, 05:00 ET High Templar Tech Announces Final Results of Modified Dutch Auction Tender Offer
which were accepted in full, and conditional tenders that were automatically regarded as withdrawn because the condition of the tender has not been met, and has been informed by the Depositary that the final proration factor for the tender offer is approximately 88.8%. The total of 39,999,926 ADSs that
More news about: High Templar Tech Limited
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Both the 15 mg and 30 mg doses of upadacitinib in each study met the primary endpoint of SALT score ≤ 20 at week 24, with significantly more patients achieving ≥ 80% scalp hair coverage compared with placebo. Key secondary endpoints were also met for both doses in both studies, including complete scalp hair
More news about: AbbVie
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Both the 15 mg and 30 mg doses of upadacitinib in each study met the primary endpoint of SALT score ≤ 20 at week 24, with significantly more patients achieving ≥ 80% scalp hair coverage compared with placebo. Key secondary endpoints were also met for both doses in both studies, including complete scalp hair
More news about: AbbVie
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
placebo-controlled, double-blind studies evaluating the efficacy and safety of upadacitinib in adult and adolescent patients with NSV. Upadacitinib 15 mg met both co-primary endpoints and key secondary endpoints, with significant improvements in total body and facial repigmentation.1 The safety
More news about: AbbVie
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
placebo-controlled, double-blind studies evaluating the efficacy and safety of upadacitinib in adult and adolescent patients with NSV. Upadacitinib 15 mg met both co-primary endpoints and key secondary endpoints, with significant improvements in total body and facial repigmentation.1 The safety
More news about: AbbVie
Jun 29, 2026, 02:00 ET Team for the Planet launches a global call for innovation, awarding €1 million each to leading climate inventors
at €1 are revalued annually against the portfolio's real worth, with one global first: gains are recognised only when a holding's climate targets are met. The figures speak plainly: €41 million raised in five years—Europe's largest crowdfunding campaign—now drawing venture capital and institutional investors."A
More news about: TEAM FOR THE PLANET
Jun 29, 2026, 02:00 ET Team for the Planet launches a global call for innovation, awarding €1 million each to leading climate inventors
at €1 are revalued annually against the portfolio's real worth, with one global first: gains are recognised only when a holding's climate targets are met. The figures speak plainly: €41 million raised in five years—Europe's largest crowdfunding campaign—now drawing venture capital and institutional investors."A
More news about: TEAM FOR THE PLANET
Jun 29, 2026, 02:00 ET Kehua, ESN et TÜV Rheinland publient conjointement un livre blanc sur le stockage énergétique grid-forming lors de l'Intersolar Europe 2026
rude épreuve par la pénétration croissante des énergies renouvelables, la baisse de l'inertie et la détérioration de l'état des réseaux. Ce livre blanc met en évidence trois enjeux essentiels : la diminution de l'inertie du réseau, le déséquilibre géographique croissant entre les zones de production riches
More news about: Kehua Digital Energy
Jun 29, 2026, 01:41 ET How Cangzhou Is Gaining From Beijing-Tianjin-Hebei Integration
concentration dropped by 11.47 percent and the number of good-air days increased by 51. Centralized drinking-water sources met Grade III or better standards, and eight rivers flowing into the sea met water-quality targets.Tourism has benefited from closer regional links and Cangzhou's cultural resources.
More news about: Xinhuanet